Flavonoids and mitochondrial pharmacology: A new paradigm for cardioprotection

Lara Testai1

  • 1Department of Pharmacy, University of Pisa, via Bonanno, 6-56100 Pisa, Italy; Interdepartmental Center of Nutraceutical Research and Food for Healthy "Nutrafood", Università di Pisa, via del Borghetto, 80-56124 Pisa, Italy.

Life Sciences
|May 27, 2015
PubMed

Insights

Flavonoids protect the heart from ischemia/reperfusion injury. This review highlights their mitochondrial mechanisms, moving beyond antioxidant effects to identify novel cardioprotective drug targets.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Mitochondrial Biology

Background:

  • Acute myocardial ischemia is a leading cause of death, necessitating new cardioprotective strategies.
  • Epidemiological and experimental studies link flavonoid-rich foods and compounds to reduced cardiovascular risk and improved outcomes during ischemia/reperfusion.
  • While antioxidant effects are known, specific molecular targets are crucial for understanding flavonoid cardioprotection.

Purpose of the Study:

  • To review the role of mitochondria in the cardioprotective mechanisms of flavonoids.
  • To explore specific biological pathways and experimental evidence related to flavonoid action on cardiac mitochondria.
  • To identify novel pharmacological targets for anti-ischemic therapies based on mitochondrial function.

Main Methods:

  • Literature review of epidemiological and experimental studies on flavonoids and cardioprotection.
  • Analysis of research focusing on flavonoid interactions with mitochondrial targets (ion channels, protein kinases).
  • Synthesis of evidence on the pharmacodynamic properties of flavonoids in myocardial ischemia/reperfusion models.

Main Results:

  • Flavonoids demonstrate significant cardioprotective effects in various animal models of myocardial ischemia/reperfusion.
  • Mitochondrial pathways, including ion channels and protein kinases, are emerging as key targets for flavonoid-mediated cardioprotection.
  • The role of flavonoids in modulating mitochondrial function is gaining recognition over their purely antioxidant properties.

Conclusions:

  • Mitochondrial mechanisms are central to the cardioprotective effects of certain flavonoids.
  • Targeting mitochondrial pathways offers promising avenues for developing novel pharmacological treatments for acute myocardial ischemia.
  • Further research into flavonoid-mitochondria interactions can advance anti-ischemic drug discovery.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.7K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.9K
Mitochondrial Membranes01:45

Mitochondrial Membranes

2.4K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.6K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.4K